When It Comes To Biosimilar Marketing, Two Roads Diverge

Amgen believes manufacturing nuances will set biosimilars apart and pave the way for Amgen to become a leader in the field. Others say it is a risky move to play up differences in the burgeoning market because of physician and patient concerns about the safety of biosimilars.